SEARCH

SEARCH BY CITATION

References

  • Akashi S., Saitoh S., Wakabayashi Y. et al. (2003) Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14. J. Exp. Med. 198, 10351042.
  • Akashi-Takamura S., Furuta T., Takahashi K., Tanimura N., Kusumoto Y., Kobayashi T., Saitoh S., Adachi Y., Doi T. and Miyake K. (2006) Agonistic antibody to TLR4/MD-2 protects mice from acute lethal hepatitis induced by TNF-alpha. J. Immunol. 176, 42444251.
  • Arumugam T. V., Chan S. L., Jo D. G. et al. (2006) Gamma secretase-mediated Notch signaling worsens brain damage and functional outcome in ischemic stroke. Nat. Med. 12, 621623.
  • Bastide M., Gele P., Petrault O., Pu Q., Caliz A., Robin E., Deplanque D., Duriez P. and Bordet R. (2003) Delayed cerebrovascular protective effect of lipopolysaccharide in parallel to brain ischemic tolerance. J. Cereb. Blood Flow Metab. 2, 399405.
  • Bernstein S. L., Guo Y., Kelman S. E., Flower R. W. and Johnson M. A. (2003) Functional and cellular responses in a novel rodent model of anterior ischemic optic neuropathy. Invest. Ophthalmol. Vis. Sci. 44, 41534162.
  • Blum D., Chtarto A., Tenenbaum L., Brotchi J. and Levivier M. (2004) Clinical potential of minocycline for neurodegenerative disorders. Neurobiol. Dis. 17, 359366.
  • Broad A., Kirby J. A. and Jones D. E. (2007) Toll-like receptor interactions: tolerance of MyD88-dependent cytokines but enhancement of MyD88-independent interferon-beta production. Immunology 120, 103111.
  • Bsibsi M., Ravid R., Gveric D. and van Noort J. M. (2002) Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 61, 10131021.
  • Buckingham B. P., Inman D. M., Lambert W., Oglesby E., Calkins D. J., Steele M. R., Vetter M. L., Marsh-Armstrong N. and Horner P. J. (2008) Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. J. Neurosci. 28, 27352744.
  • Bye N., Habgood M. D., Callaway J. K., Malakooti N., Potter A., Kossmann T. and Morganti-Kossmann M. C. (2007) Transient neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neutrophil infiltration. Exp. Neurol. 204, 220233.
  • Cao C. X., Yang Q. W., Lv F. L., Cui J., Fu H. B. and Wang J. Z. (2007) Reduced cerebral ischemia-reperfusion injury in Toll-like receptor 4 deficient mice. Biochem. Biophys. Res. Commun. 353, 509514.
  • Caso J. R., Pradillo J. M., Hurtado O., Lorenzo P., Moro M. A. and Lizasoain I. (2007) Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation 115, 15991608.
  • Cervia D. and Casini G. (2012) Recent advances in cellular and molecular aspects of mammalian retinal ischemia. World J. Pharmacol. 1, 3043.
  • Chen Z., Jalabi W., Shpargel K. B., Farabaugh K. T., Dutta R., Yin X., Kidd G. J., Bergmann C. C., Stohlman S. A. and Trapp B. D. (2012) Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4. J. Neurosci. 32, 1170611715.
  • Danton G. H. and Dietrich W. D. (2003) Inflammatory mechanisms after ischemia and stroke. J. Neuropathol. Exp. Neurol. 62, 127136.
  • Denes A., Vidyasagar R., Feng J., Narvainen J., McColl B. W., Kauppinen R. A. and Allan S. M. (2007) Proliferating resident microglia after focal cerebral ischaemia in mice. J. Cereb. Blood Flow Metab. 27, 19411953.
  • Du Y., Ma Z., Lin S. et al. (2001) Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc. Natl Acad. Sci. USA 98, 1466914674.
  • Dvoriantchikova G., Barakat D. J., Hernandez E., Shestopalov V. I. and Ivanov D. (2010) Toll-like receptor 4 contributes to retinal ischemia/reperfusion Injury. Mol. Vis. 16, 19071912.
  • Fan L. W., Pang Y., Lin S., Rhodes P. G. and Cai Z. (2005) Minocycline attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain. Neuroscience 133, 159168.
  • Fujita R., Ueda M., Fujiwara K. and Ueda H. (2009) Prothymosin-alpha plays a defensive role in retinal ischemia through necrosis and apoptosis inhibition. Cell Death Differ. 16, 349358.
  • Guha M. and Mackman N. (2001) LPS induction of gene expression in human monocytes. Cell. Signal. 13, 8594.
  • Halder S. K., Matsunaga H. and Ueda H. (2012) Neuron-specific non-classical release of prothymosin alpha: a novel neuroprotective damage-associated molecular patterns. J. Neurochem. 123, 262275.
  • Halder S. K., Matsunaga H., Yamaguchi H. and Ueda H. (2013) Novel neuroprotective action of prothymosin alpha-derived peptide against retinal and brain ischemic damages. J. Neurochem. doi:10.1111/jnc.12132 (in press).
  • Hernandez M., Rodriguez F. D., Sharma S. C. and Vecino E. (2009) Immunohistochemical changes in rat retinas at various time periods of elevated intraocular pressure. Mol. Vis. 15, 26962709.
  • Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K. and Akira S. (1999) Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162, 37493752.
  • Hua F., Ma J., Ha T. et al. (2007) Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion. J. Neuroimmunol. 190, 101111.
  • Hyakkoku K, Hamanaka J., Tsuruma K., Shimazawa M., Tanaka H., Uematsu S., Akira S., Inagaki N., Nagai H. and Hara H. (2010) Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia. Neuroscience 171, 258267.
  • Iadecola C. and Anrather J. (2011) The immunology of stroke: from mechanisms to translation. Nat. Med. 17, 796808.
  • Ibrahim A. S., El-Remessy A. B., Matragoon S., Zhang W., Patel Y., Khan S., Al-Gayyar M. M., El-Shishtawy M. M. and Liou G. I. (2011) Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes. Diabetes 60, 11221133.
  • Jack C. S., Arbour N., Manusow J., Montgrain V., Blain M., McCrea E., Shapiro A. and Antel J. P. (2005) TLR signaling tailors innate immune responses in human microglia and astrocytes. J. Immunol. 175, 43204330.
  • Jehle T., Wingert K., Dimitriu C., Meschede W., Lasseck J., Bach M. and Lagrèze W. A. (2008) Quantification of ischemic damage in the rat retina: a comparative study using evoked potentials, electroretinography, and histology. Invest. Ophthalmol. Vis. Sci. 49, 10561064.
  • Jeong H. K., Jou I. and Joe E. H. (2010) Systemic LPS administration induces brain inflammation but not dopaminergic neuronal death in the substantia nigra. Exp. Mol. Med. 42, 823832.
  • Jin S. X., Zhuang Z. Y., Woolf C. J. and Ji R. R. (2003) p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J. Neurosci. 23, 40174022.
  • Kaur C., Foulds W. S. and Ling E. A. (2008) Hypoxia-ischemia and retinal ganglion cell damage. Clin. Ophthalmol. 2, 879889.
  • Kawai T. and Akira S. (2007) TLR signaling. Semin. Immunol. 19, 2432.
  • Ko M. K., Saraswathy S., Parikh J. G. and Rao N. A. (2011) The role of TLR4 activation in photoreceptor mitochondrial oxidative stress. Invest. Ophthalmol. Vis. Sci. 52, 58245835.
  • Koistinaho M. and Koistinaho J. (2002) Role of p38 and p44/42 mitogen-activated protein kinases in microglia. Glia 40, 175183.
  • Krady J. K., Basu A., Allen C. M., Xu Y., LaNoue K. F., Gardner T. W. and Levison S. W. (2005) Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 54, 15591565.
  • Lai A. Y. and Todd K. G. (2006) Microglia in cerebral ischemia: molecular actions and interactions. Can. J. Physiol. Pharmacol. 84, 4959.
  • Lakhan S. E., Kirchgessner A. and Hofer M. (2009) Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J. Transl. Med. 7, 97.
  • Lalancette-Hebert M., Gowing G., Simard A., Weng Y. C. and Kriz J. (2007) Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J. Neurosci. 27, 25962605.
  • Lambertsen K. L., Clausen B. H., Babcock A. A. et al. (2009) Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J. Neurosci. 29, 13191330.
  • Langmann T. (2007) Microglia activation in retinal degeneration. J. Leukoc. Biol. 81, 13451351.
  • Lehnardt S., Schott E., Trimbuch T., Laubisch D., Krueger C., Wulczyn G., Nitsch R. and Weber J. R. (2008) A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS. J. Neurosci. 28, 23202331.
  • Liang H., Brignole-Baudouin F., Labbé A., Pauly A., Warnet J. M. and Baudouin C. (2007) LPS-stimulated inflammation and apoptosis in corneal injury models. Mol. Vis. 13, 11691180.
  • Lipton P. (1999) Ischemic cell death in brain neurons. Physiol. Rev. 79, 14311568.
  • Litvak V., Ramsey S. A., Rust A. G., Zak D. E., Kennedy K. A., Lampano A. E., Nykter M., Shmulevich I. and Aderem A. (2009) Function of C/EBPdelta in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals. Nat. Immunol. 10, 437443.
  • Mabuchi T., Kitagawa K., Ohtsuki T., Kuwabara K., Yagita Y., Yanagihara T., Hori M. and Matsumoto M. (2000) Contribution of microglia/macrophages to expansion of infarction and response of oligodendrocytes after focal cerebral ischemia in rats. Stroke 31, 17351743.
  • Maitra U., Deng H., Glaros T., Baker B., Capelluto D. G., Li Z. and Li L. (2012) Molecular mechanisms responsible for the selective and low-grade induction of proinflammatory mediators in murine macrophages by lipopolysaccharide. J. Immunol. 189, 10141023.
  • Marsh B., Stevens S. L., Packard A., Gopalan B., Hunter B., Leung P. Y., Harrington C. A. and Stenzel-Poore M. P. (2009a) Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: a critical role for IRF3. J. Neurosci. 29, 98399849.
  • Marsh B. J., Williams-Karnesky R. L. and Stenzel-Poore M. P. (2009b) Toll-like receptor signaling in endogenous neuroprotection and stroke. Neuroscience 158, 10071020.
  • Masland R. H. (2012) The neuronal organization of the retina. Neuron 76, 266280.
  • Neroev V. V., Zueva M. V. and Kalamkarov G. R. (2010) Molecular mechanisms of retinal ischemia. Vestn. oftalmol. 126, 5964.
  • Neufeld A. H., Si Kawai, Das S., Vora S., Gachie E., Connor J. R. and Manning P. T. (2002) Loss of retinal ganglion cells following retinal ischemia: the role of inducible nitric oxide synthase. Exp. Eye Res. 75, 521528.
  • Obrenovitch T. P. (2008) Molecular physiology of preconditioning-induced brain tolerance to ischemia. Physiol. Rev. 88, 211247.
  • Olson J. K. and Miller S. D. (2004) Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 173, 39163924.
  • Osborne N. N., Casson R. J., Wood J. P., Chidlow G., Graham M. and Melena J. (2004) Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog. Retin. Eye Res. 23, 91147.
  • Palsson-McDermott E. M. and O'Neill L. A. (2004) Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 113, 153162.
  • Pang Y., Fan L. W., Zheng B., Campbell L. R., Cai Z. and Rhodes P. G. (2012) Dexamethasone and betamethasone protect against lipopolysaccharide-induced brain damage in neonatal rats. Pediatr. Res. 71, 552558.
  • Perlman I. (2009) Testing retinal toxicity of drugs in animal models using electrophysiological and morphological techniques. Doc. Ophthalmol. 118, 328.
  • Piao W., Song C., Chen H., Diaz M. A., Wahl L. M., Fitzgerald K. A., Li L. and Medvedev A. E. (2009) Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling. J. Leukoc. Biol. 86, 863875.
  • Plane J. M., Shen Y., Pleasure D. E. and Deng W. (2010) Prospects for minocycline neuroprotection. Arch. Neurol. 67, 14421448.
  • Pradillo J. M., Fernandez-Lopez D., Garcia-Yebenes I., Sobrado M., Hurtado O., Moro M. A. and Lizasoain I. (2009) Toll-like receptor 4 is involved in neuroprotection afforded by ischemic preconditioning. J. Neurochem. 109, 287294.
  • Qin L., Wu X., Block M. L., Liu Y., Breese G. R., Hong J. S., Knapp D. J. and Crews F. T. (2007) Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55, 453462.
  • Raghavendra V., Tanga F. and DeLeo J. A. (2003) Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J. Pharmacol. Exp. Ther. 306, 624630.
  • Ransohoff R. M. and Perry V. H. (2009) Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 27, 119145.
  • Rhee K. D., Ruiz A., Duncan J. L., Hauswirth W. W., Lavail M. M., Bok D. and Yang X. J. (2007) Molecular and cellular alterations induced by sustained expression of ciliary neurotrophic factor in a mouse model of retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. 48, 13891400.
  • Rosenzweig H. L., Lessov N. S., Henshall D. C., Minami M., Simon R. P. and Stenzel-Poore M. P. (2004) Endotoxin preconditioning prevents the cellular inflammatory response during ischemic neuroprotection in mice. Stroke 35, 25762581.
  • Roth S., Shaikh A. R., Hennelly M. M., Li Q., Bindokas V. and Graham C. E. (2003) Mitogen-activated protein kinases and retinal ischemia. Invest. Ophthalmol. Vis. Sci. 44, 53835395.
  • Sheng J. G., Bora S. H., Xu G., Borchelt D. R., Price D. L. and Koliatsos V. E. (2003) Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice. Neurobiol. Dis. 14, 133145.
  • Sherry D. M., Mitchell R., Standifer K. M. and du Plessis B. (2006) Distribution of plasma membrane-associated syntaxins 1 through 4 indicates distinct trafficking functions in the synaptic layers of the mouse retina. BMC Neurosci. 7, 54.
  • Shimazawa M., Yamashima T., Agarwal N. and Hara H. (2005) Neuroprotective effects of minocycline against in vitro and in vivo retinal ganglion cell damage. Brain Res. 1053, 185194.
  • Shpargel K. B., Jalabi W., Jin Y., Dadabayev A., Penn M. S. and Trapp B. D. (2008) Preconditioning paradigms and pathways in the brain. Cleve. Clin. J. Med. 75, 7782.
  • Stevens S. L., Leung P. Y., Vartanian K. B., Gopalan B., Yang T., Simon R. P. and Stenzel-Poore M. P. (2011) Multiple preconditioning paradigms converge on interferon regulatory factor-dependent signaling to promote tolerance to ischemic brain injury. J. Neurosci. 31, 84568463.
  • Streit W. J. (2002) Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 40, 133139.
  • Tasaki K., Ruetzler C. A., Ohtsuki T., Martin D., Nawashiro H. and Hallenbeck J. M. (1997) Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Res. 748, 267270.
  • Tikka T., Fiebich B. L., Goldsteins G., Keinanen R. and Koistinaho J. (2001) Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J. Neurosci. 21, 25802588.
  • Uckermann O., Uhlmann S., Pannicke T. et al. (2005) Ischemia-reperfusion causes exudative detachment of the rabbit retina. Invest. Ophthalmol. Vis. Sci. 46, 25922600.
  • Ueda H. and Fujita R. (2004) Cell death mode switch from necrosis to apoptosis in brain. Biol. Pharm. Bull. 27, 950955.
  • Ueda H., Matsunaga H., Uchida H. and Ueda M. (2010) Prothymosin alpha as robustness molecule against ischemic stress to brain and retina. Ann. N. Y. Acad. Sci. 1194, 2026.
  • Ueda H., Matsunaga H. and Halder S. K. (2012) Prothymosin α–a novel endogenous neuroprotective polypeptide against ischemic damages, in Neuropeptides in Neuroprotection and Neuroregeneration (Nyberg F. J., ed.), pp. 128143. CRC Press Taylor & Francis Group, Abingdon.
  • Vartanian K. B. and Stenzel-Poore M. (2010) Toll-like receptor tolerance as a mechanism for neuroprotection. Transl. Stroke Res. 1, 252260.
  • Vartanian K. B., Stevens S. L., Marsh B. J., Williams-Karnesky R., Lessov N. S. and Stenzel-Poore M. P. (2011) LPS preconditioning redirects TLR signaling following stroke: TRIF-IRF3 plays a seminal role in mediating tolerance to ischemic injury. J. Neuroinflammation 8, 140.
  • Wang A. L., Yu A. C., Lau L. T., Lee C., le Wu M., Zhu X. and Tso M. O. (2005) Minocycline inhibits LPS-induced retinal microglia activation. Neurochem. Int. 47, 152158.
  • Wang Y. C., Lin S. and Yang Q. W. (2011) Toll-like receptors in cerebral ischemic inflammatory injury. J. Neuroinflammation 8, 134.
  • Xiao O., Xie Z. L., Lin B. W., Yin X. F., Pi R. B. and Zhou S. Y. (2012) Minocycline inhibits alkali burn-induced corneal neovascularization in mice. PLoS ONE 7, e41858.
  • Yang L., Zhu X. and Tso M. (2007) Minocycline and sulforaphane inhibited lipopolysaccharide-mediated retinal microglial activation. Mol. Vis. 13, 10831093.
  • Zeng H. Y., Zhu X. A., Zhang C., Yang L. P., Wu L. M. and Tso M. O. (2005) Identification of sequential events and factors associated with microglial activation, migration, and cytotoxicity in retinal degeneration in rd mice. Invest. Ophthalmol. Vis. Sci. 46, 29922999.